Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

1712667

registered interest
date	22/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to (a) trial and (b) roll-out early cancer screening.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	22951
answer	answer is ministerial correction date of answer 24/04/2024 answer text <p>In England, early cancer screening is already in place for cervical, breast, and bowel cancer. The UK National Screening Committee (UK NSC) does not currently recommend screening for prostate cancer due to the inaccuracy of the current best test, called Prostate Specific Antigen. We are providing £16 million of funding to Prostate Cancer UK's £42 million trial, which is aimed at helping us find a way of catching prostate cancer in men as early as possible. The UK NSC is also commissioning evidence for six possible approaches to targeted prostate screening for those at higher risk. The UK NSC will publish its recommendations when complete.</p><p>NHS England is responsible for the running of the Targeted Lung Health Check Programme, and its conversion to a nationally rolled out NHS Targeted Lung Cancer Screening Programme by 2030.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 24/04/2024 14:48:02 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4131 label Biography information for Jim Shannon

1698336

registered interest
date	25/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 30 January 2024, how frequently the Minister of State for Health and Secondary Care and the Parliamentary Under Secretary of State for Public Health, Start of for Life and Primary Car meet to discuss arrangements under section 7A for cancer screening; and on what date they last discussed that matter.
tabling member constituency	Colne Valley
tabling member printed	Jason McCartney
uin	20269
answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>Arrangements under the section 7A agreement are negotiated at an official level. Health ministers are sighted in these arrangements, and have the opportunity to steer the process, usually feeding in through their private offices.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 15/04/2024 08:57:14 answering member 4044 label Biography information for Andrew Stephenson
tabling member	3953 label Biography information for Jason McCartney

1694454

registered interest
date	07/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what her expected timescale is for the availability of the Galleri blood test in cancer testing and diagnosis across the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	17545
answer	answer is ministerial correction date of answer 13/03/2024 answer text <p>The NHS-Galleri trial is looking into the use of a new blood test to see if it can help the National Health Service to detect cancer early, when used alongside existing cancer screening. The trial recruited the target of 140,000 participants, and interim results are expected in spring or summer 2024.</p><p>If the trial is successful, the NHS has committed to rolling out up to one million Galleri tests in 2024 and 2025, as part of an interim implementation pilot. The clinical trial is currently planned to conclude in 2025, with results expected in 2026.</p><p>Should the final results be positive, the UK National Screening Committee (UK NSC) may consider the use of the test in a national screening programme. A UK NSC-recommended national screening programme would need to consider the effectiveness of the test, balancing the risk of false positives and unnecessary invasive treatments, against potential early detection.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 13/03/2024 15:09:07 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4131 label Biography information for Jim Shannon

1685955

registered interest
date	30/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many and what proportion of women who (a) have and (b) do not have multiple sclerosis attended (i) cancer screening appointments, (ii) mammograms and (iii) cervical screening appointments in each of the last five years.
tabling member constituency	East Renfrewshire
tabling member printed	Kirsten Oswald
uin	12122
answer	answer is ministerial correction date of answer 06/02/2024 answer text <p>National Health Service screening programmes do not collect data on an individual’s long-term condition, and therefore no data is available on what proportion of women who have multiple sclerosis, participate in cancer screening programmes.</p><p>Under the Equality Act 2010, and the Health and Social Care Act 2012, NHS screening providers have a legal duty to make sure screening services are accessible to everyone, including people with long term conditions, who may have issues with access.</p><p>The following table provides data on the percentage of coverage for the three cancer screening programmes, breast, cervical and bowel, within the age groups invited for NHS screenings, in England over the last five years:<br></p><table><tbody><tr><td><p> </p></td><td><p>2016/17</p></td><td><p>2017/18</p></td><td><p>2018/19</p></td><td><p>2019/20</p></td><td><p>2020/21</p></td><td><p>2021/22</p></td></tr><tr><td><p>Breast Screening – ages 50 to 71 years old</p></td><td><p>74.9%</p></td><td><p>74.6%</p></td><td><p>74.2%</p></td><td><p>64.2%</p></td><td><p>65.3%</p></td><td><p>66.4%</p></td></tr><tr><td><p>Cervical Screening – ages 25 to 64 years old</p></td><td><p>71.4%</p></td><td><p>71.9%</p></td><td><p>72.2%</p></td><td><p>70.2%</p></td><td><p>69.9%</p></td><td><p>68.7%</p></td></tr><tr><td><p>Bowel Screening – ages 60 to 74 years old</p></td><td><p>59.2%</p></td><td><p>59.5%</p></td><td><p>60.5%</p></td><td><p>64.3%</p></td><td><p>66.1%</p></td><td><p>70.3%</p></td></tr></tbody></table><p><strong><br> </strong>Note: Data for bowel cancer screening is not separated based on sex.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 06/02/2024 17:21:49 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4413 label Biography information for Kirsten Oswald

1685690

registered interest
date	29/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Screening
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what oversight they are exercising over the NHS-Galleri trial.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1993
answer	answer is ministerial correction date of answer 05/02/2024 answer text <p>In 2021 the United Kingdom and devolved administrations set out their vision for the future of clinical research delivery, including for the NHS Galleri trial. Saving and Improving Lives: The Future of UK Clinical Research Delivery lays out the ambition to create a world-leading UK clinical research environment that is more efficient, more effective and more resilient, with research delivery embedded across the National Health Service. A copy of this document is attached.</p><p>The cross-sector partnerships built through the UK Clinical Research Recovery, Resilience and Growth (RRG) programme provide the strong foundations needed to succeed, drawing on expertise and support from industry, academia, charities, patients and the public, regulators, funders and the NHS. The RRG programme provides system leadership, oversight and strategic co-ordination of the work in order to implement the plans and deliver the ambitions set. It is co-ordinated by the Department and is making progress across a number of commitments.</p> answering member printed Lord Markham question first answered 05/02/2024 12:23:57 answering member 4948 label Biography information for Lord Markham attachment 1 file name The-future-of-UK-clinical-research-delivery.pdf title The Future of UK Clinical Research Delivery
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1684980

registered interest
date	24/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Screening
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government to what extent they have evaluated in the NHS-Galleri research trial the possibility that patients with small tumours will not be readily detected when circulating tumour DNA is used for diagnosis, leading to poor utility for cancer screening.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1891
answer	answer is ministerial correction date of answer 30/01/2024 answer text <p>The Department has not made any formal evaluations, as the NHS-Galleri research trial is currently still ongoing. The trial is planned to conclude in 2025 with interim results expected during 2024, and final results anticipated in 2026.</p> answering member printed Lord Markham question first answered 30/01/2024 11:36:37 answering member 4948 label Biography information for Lord Markham
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1684534

registered interest
date	23/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Answer of 30 June 2023 to Question 190710 on Cancer: Screening, if she will publish (a) the NHS breast cancer screening uptake improvement plan and (b) an update on the (i) pilot and (ii) testing conducted.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	11066
answer	answer is ministerial correction date of answer 29/01/2024 answer text <p>NHS England has developed an internal national plan in collaboration with key stakeholders, to improve uptake within the breast screening programme from 2023 and beyond. There is currently no intention to publish the plan, but it is available on the NHS Futures Platform. This is a collaboration platform that empowers everyone working in health and social care to safely connect, share, and learn across boundaries.</p><p> </p><p>NHS England has commissioned a series of evaluative projects as part of its internal national improvement plan for breast screening, which includes: actively following up with women who have missed an appointment or not engaged with the service; looking at the reasons why women do not attend screenings to address any barriers; and assessing the impact on screening uptake of using different invitation methodologies with reference to factors such as age, previous screening history, attendance at first invitation and subsequent invites, and deprivation. These projects are expected to report their findings by April 2024.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 29/01/2024 15:50:51 answering member 4044 label Biography information for Andrew Stephenson
tabling member	3973 label Biography information for Grahame Morris

1681618

registered interest
date	11/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she plans to take to increase levels of take up for cancer screening, in the context of lessons learnt on reaching hard-to-reach groups in the lung cancer screening programme.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	9250
answer	answer is ministerial correction date of answer 17/01/2024 answer text <p>1,241,038 people have been invited for a lung cancer check, as part of the biggest programme to improve early lung cancer diagnosis in the history of the National Health Service. The Targeted Lung Health Check uses vans parked in supermarkets or sports stadium car parks. Risk assessments are often carried out over the phone.</p><p>The national targeted lung cancer screening programme will implement a standard IT system that will ensure consistent call and recall so that people are invited regularly.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 17/01/2024 17:21:09 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4471 label Biography information for Rachael Maskell

1671700

registered interest
date	21/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans she has for use of the Galleri blood test in cancer testing and diagnosis across the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	2891
answer	answer is ministerial correction date of answer 27/11/2023 answer text <p>The NHS-Galleri Trial is looking into the use of a new blood test to see if it can help the National Health Service to detect cancer early when used alongside existing cancer screening. The trial has now recruited the target of 140,000 participants and interim results are expected in spring or summer 2024. If the trial is successful, the NHS has committed to rolling out up to one million Galleri tests in 2024 and 2025 as part of an interim implementation pilot. The clinical trial is currently planned to conclude in 2025 with results expected in 2026.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 27/11/2023 15:56:34 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4131 label Biography information for Jim Shannon

1669873

registered interest
date	14/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential merits of lowering the screening age for (a) lung, (b) breast, (c) bowel and (d) other cancers.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	1929
answer	answer is ministerial correction date of answer 20/11/2023 answer text <p>Decisions on the age eligibility for national screening programmes is set in recommendations from the UK National Screening Committee (UK NSC). The UK NSC makes informed decisions on age eligibility based on scientific evidence on the effectiveness and harms to different age cohorts if they are invited to be screened.</p><p>Th UK NSC works to review and adapt programmes according to the latest scientific evidence. Following a UK NSC recommendation, the bowel cancer screening programme is currently lowing the eligible age to 50 years old from 60 years old. This is due to be finished by 2024/25. UK NSC awaits the outcome of a large research project called AgeX which is looking at the upper and lower age limit for breast screening.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 20/11/2023 16:38:08 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4471 label Biography information for Rachael Maskell